Siemens Forms New Molecular Imaging Division

Siemens announced it has formed a new division called Siemens Medical Solutions Molecular Imaging, which combines its nuclear medicine operations with CTI Molecular Imaging - a provider of positron emission technology imaging equipment and services, and now a wholly owned subsidiary of Siemens Medical Solutions. This announcement comes after the May 4 expiration of Siemens' tender offer to acquire all of the issued and outstanding shares of CTI stock at $20.50 per share. The transaction has a total value of approximately $1 billion.

()a href="http://www.genengnews.com/news/bnitem.aspx?name=548306XSL_NEWSML_TO_NEWSML_WEB.xml" target="_blank">Genetic Engineering News